Drugs for the treatment of overactive bladder syndrome: present and future (A Review)

被引：0

作者：

Shvarts, G. Ya. ^{[1
]}

Shvarts, P. G. ^{[2
]}

Plotnikov, A. N. ^{[2
]}

Savvin, D. Yu. ^{[2
]}

机构：

[1] Sechenov First Moscow State Med Univ, Moscow 119991, Russia

[2] Russian Acad Med Sci, Res Ctr Neurol, Moscow 125367, Russia

来源：

PHARMACEUTICAL CHEMISTRY JOURNAL | 2013年 / 46卷 / 12期

关键词：

overactive bladder syndrome; anticholinergic drugs; LOWER URINARY-TRACT; DYSFUNCTION PATHOPHYSIOLOGY; DETRUSOR OVERACTIVITY; MIRABEGRON; FOREFRONT; SYMPTOMS; EFFICACY;

D O I：

10.1007/s11094-013-0873-x

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Published data concerning drugs currently used for the treatment of overactive bladder (OAB) syndrome were reviewed. Modern notions about the physiology and pathophysiology of micturition were considered and data on the pharmacological properties, tolerance, and therapeutic efficiency of anticholinergic drugs (antimuscarinic agents), the first-line drugs for treating OAB, were presented. Data on drugs with a different mechanism of action that are currently used to treat OAB were reviewed. Information on the principal directions of new drug development, in particular, beta 3-adrenoreceptor agonists, compounds affecting KCNQ/Kv7-channels, vitamin D receptors, etc., was summarized.

引用

页码：699 / 706

页数：8

共 50 条

[1] Drugs for the treatment of overactive bladder syndrome: present and future (A Review)
G. Ya. Shvarts
P. G. Shvarts
A. N. Plotnikov
D. Yu. Savvin
Pharmaceutical Chemistry Journal, 2013, 46 : 699 - 706
[2] Treatment of overactive bladder: Past, present, and future
Kuo, Hann-Chorng
UROLOGICAL SCIENCE, 2015, 26 (01) : 1 - +
[3] Overactive bladder syndrome pharmacotherapy: future treatment options
Wrobel, Andrzej
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2015, 14 (04): : 211 - 217
[4] Cost implications of antimuscarinic drugs in the treatment of overactive bladder syndrome
Perimenis, P
Konstantinopoulos, A
Giannitsas, K
Athanasopoulos, A
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (05) : 539 - 544
[5] Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder
Tyagi, Pradeep
Kashyap, Mahendra
Yoshimura, Naoki
Chancellor, Michael
Chermansky, Christopher J.
JOURNAL OF UROLOGY, 2017, 197 (04): : 982 - 990
[6] Future Directions in Overactive Bladder Treatment
Kaufman M.R.
Current Bladder Dysfunction Reports, 2011, 6 (1) : 45 - 50
[7] Mirabegron: A Review in Overactive Bladder Syndrome
Deeks, Emma D.
DRUGS, 2018, 78 (08) : 833 - 844
[8] Mirabegron: A Review in Overactive Bladder Syndrome
Emma D. Deeks
Drugs, 2018, 78 : 833 - 844
[9] Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects
Tilborghs, Sam
De Wachter, Stefan
EXPERT REVIEW OF MEDICAL DEVICES, 2022, 19 (02) : 161 - 187
[10] Anticholinergic treatment of overactive bladder syndrome
Schneider, T.
Michel, M. C.
UROLOGE, 2009, 48 (03): : 245 - +

← 1 2 3 4 5 →